BioPharmX
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch BioPharmX and buy or sell other stocks, ETFs, and their options commission-free!About BPMX
BioPharmX Corp. is a specialty pharmaceutical company focused on developing prescription products utilizing its proprietary HyantX Topical Delivery System for dermatology indications. The HyantX delivery system is designed to stabilize and solubilize hydrophilic molecules in an anhydrous gel environment.
CEOSteven M. Bosacki, MBA
CEOSteven M. Bosacki, MBA
Employees—
Employees—
HeadquartersCampbell, California
HeadquartersCampbell, California
Founded2010
Founded2010
Employees—
Employees—
BPMX Key Statistics
Market cap300.00
Market cap300.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.49K
Average volume1.49K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.36
52 Week high$3.36
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
BioPharmX(BPMX) stock is priced at $3.09, giving the company a market capitalization of 300.
On 2025-12-17, BioPharmX(BPMX) stock opened at —, reached a high of —, and a low of —.
The BioPharmX(BPMX)'s current trading volume is 0, compared to an average daily volume of 1.49K.
In the last year, BioPharmX(BPMX) shares hit a 52-week high of $3.36 and a 52-week low of $0.00.
In the last year, BioPharmX(BPMX) shares hit a 52-week high of $3.36 and a 52-week low of $0.00.